• Amsterdam UMC, Vrije Universiteit Amsterdam, Hematology Laboratory, Cancer Center Amsterdam, De Boelelaan 1117 Amsterdam The Netherlands

1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Chapter
2017

Re-emerging antimetabolites with novel mechanism of action with respect to epigenetic regulation: Basic aspects

Sarkisjan, D., Steenbergen, R. D. M., Cloos, J. & Peters, G. J., 17 Apr 2017, Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer Singapore, p. 311-326 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

2015

Flow cytometric MRD and leukemia stem cell frequency assessment to develop risk-stratified approaches in AML

Schuurhuis, G. J., Zeijlemaker, W. & Cloos, J., 2015, Annals of Hematology. G.J. Schuurhuis, Department of Hematology, Amsterdam, Netherlands: Springer Verlag, p. S49-S51 (Annals of Hematology; vol. 94).

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

2014

Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies.

Cloos, J., Niewerth, D. & Jansen, G., 2014, Resistance to proteasome inhibitors in cancer. p. 181-204

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

2008

Proteasome and protease inhibitors

Franke, N. E., Vink, J., Cloos, J. & Kaspers, G. J. L., 2008, Innovative Leukemia and Lymfoma Therapy. New York: Informa Healthcare, p. 469-489

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Tyrosine phosphatases as new treatment targets in acute myeloid leukemia

Hubeek, I., Hoorweg-Nijman, J. J. G., Cloos, J. & Kaspers, G. J. L., 2008, Innovative Leukemia and Lymfoma Therapy. New York: Informa Healthcare, p. 449-468

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic